Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C

Journal of Immunological Methods

Volumn 285, Issue 1, 2004, Pages 1-14

  Prinz, Deborah M ^a   Smithson, S Louise ^a   Westerink, M A Julie ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Capsular polysaccharides; Neisseria meningitidis; Peptide mimicry

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; PEPTIDE; PEPTIDE LIBRARY; POLYSACCHARIDE;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INTERMETHOD COMPARISON; MENINGOCOCCOSIS; MOLECULAR MIMICRY; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN MOTIF;

NEISSERIA; NEISSERIA MENINGITIDIS SEROGROUP C;

EID: 0442292291     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2003.08.005     Document Type: Article

References (69)

1. Amersdorfer P., Wong C., Smith T., Chen S., Deshpande S., Sheridan R., Marks J.D. Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries. Vaccine. 20:2002;1640-1648.
2. Anon. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mort. Wkly. Rep., Recomm. Rep. 46:1997;13-21.
3. Anon. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mort. Wkly. Rep., Recomm. Rep. 49:2000;1-10.
4. Apicella M. Neisseria meningitidis. Mandell G.L., Douglas R.G., Bennett J.E., Dolin R. Principles and Practice of Infectious Diseases. vol. 2:2000;2228-2240 Churchill Livingstone, Philadelphia.
5. Ball R., Braun M.M., Mootrey G.T. Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting System. Clin. Infect. Dis. 32:2001;1273-1280.
6. Breukels M.A., Spanjaard L., Sanders L.A., Rijkers G.T. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants. Clin. Infect. Dis. 32:2001;1700-1705.
7. Cadoz M. Potential and limitations of polysaccharide vaccines in infancy. Vaccine. 16:1998;1391-1395.
8. Calver G.A., Kenny C.P., Lavergne G. Iron as a replacement for mucin in the establishment of meningococcal infection in mice. Can. J. Microbiol. 22:1976;832-838.
9. Cortese R., Monaci P., Nicosia A., Luzzago A., Felici F., Galfre G., Pessi A., Tramontano A., Sollazzo M. Identification of biologically active peptides using random libraries displayed on phage. Curr. Opin. Biotechnol. 6:1995;73-80.
10. Cortese R., Monaci P., Luzzago A., Santini C., Bartoli F., Cortese I., Fortugno P., Galfre G., Nicosia A., Felici F. Selection of biologically active peptides by phage display of random peptide libraries. Curr. Opin. Biotechnol. 7:1996;616-621.
11. Cwirla S.E., Peters E.A., Barrett R.W., Dower W.J. Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. U. S. A. 87:1990;6378-6382.
12. Davis C.A., Vallota E.H., Forristal J. Serum complement levels in infancy: age related changes. Pediatr. Res. 13:1979;1043-1046.
13. Devlin J.J., Panganiban L.C., Devlin P.E. Random peptide libraries: a source of specific protein binding molecules. Science. 249:1990;404-406.
14. Felici F., Castagnoli L., Musacchio A., Jappelli R., Cesareni G. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J. Mol. Biol. 222:1991;301-310.
15. Fleuridor R., Lees A., Pirofski L. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J. Immunol. 166:2001;1087-1096.
16. Frasch C.E., Zollinger W.D., Poolman J.T. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7:1985;504-510.
17. Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus: I. The role of humoral antibodies. J. Exp. Med. 129:1969;1307-1326.
18. Gotschlich E.C., Liu T.Y., Artenstein M.S. Human immunity to the meningococcus: 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J. Exp. Med. 129:1969;1349-1365.
19. Greenspan N.S., Bona C.A. Idiotypes: structure and immunogenicity. FASEB J. 7:1993;437-444.
20. Grothaus M.C., Srivastava N., Smithson S.L., Kieber-Emmons T., Williams D.B., Carlone G.M., Westerink M.A. Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library. Vaccine. 18:2000;1253-1263.
21. Gulati S., McQuillen D.P., Sharon J., Rice P.A. Experimental immunization with a monoclonal anti-idiotope antibody that mimics the Neisseria gonorrhoeae lipooligosaccharide epitope 2C7. J. Infect. Dis. 174:1996;1238-1248.
22. Heath P.T., Booy R., Griffiths H., Clutterbuck E., Azzopardi H.J., Slack M.P., Fogarty J., Moloney A.C., Moxon E.R. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin. Infect. Dis. 31:2000;973-980.
23. Hoess R., Brinkmann U., Handel T., Pastan I. Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene. 128:1993;43-49.
24. Jackson L.A., Schuchat A., Reeves M.W., Wenger J.D. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA. 273:1995;383-389.
25. Jerne N.K. Towards a network theory of the immune system. Ann. Immunol. (Paris). 125C:1974;373-389.
26. King W.J., MacDonald N.E., Wells G., Huang J., Allen U., Chan F., Ferris W., Diaz-Mitoma F., Ashton F. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children. J. Pediatr. 128:1996;196-202.
27. Leach A., Twumasi P.A., Kumah S., Banya W.S., Jaffar S., Forrest B.D., Granoff D.M., LiButti D.E., Carlone G.M., Pais L.B., Broome C.V., Greenwood B.M. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J. Infect. Dis. 175:1997;200-204.
28. Lesinski G.B., Smithson S.L., Srivastava N., Chen D., Widera G., Westerink M.A. A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice. Vaccine. 19:2001;1717-1726.
29. Lingappa J.R., Rosenstein N., Zell E.R., Shutt K.A., Schuchat A., Perkins B.A. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States. Vaccine. 19:2001;4566-4575.
30. Lowell G.H., Ballou W.R., Smith L.F., Wirtz R.A., Zollinger W.D., Hockmeyer W.T. Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides. Science. 240:1988;800-802.
31. Lowell G.H., Smith L.F., Seid R.C., Zollinger W.D. Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants. J. Exp. Med. 167:1988;658-663.
32. Luo P., Canziani G., Cunto-Amesty G., Kieber-Emmons T. A molecular basis for functional peptide mimicry of a carbohydrate antigen. J. Biol. Chem. 275:2000;16146-16154.
33. Maslanka S.E., Gheesling L.L., Libutti D.E., Donaldson K.B., Harakeh H.S., Dykes J.K., Arhin F.F., Devi S.J., Frasch C.E., Huang J.C., Kriz-Kuzemenska P., Lemmon R.D., Lorange M., Peeters C.C., Quataert S., Tai J.Y., Carlone G.M. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin. Diagn. Lab. Immunol. 4:1997;156-167.
34. Moe G.R., Tan S., Granoff D.M. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease. FEMS Immunol. Med. Microbiol. 26:1999;209-226.
35. Monafo W.J., Greenspan N.S., Cebra-Thomas J.A., Davie J.M. Modulation of the murine immune response to streptococcal group A carbohydrate by immunization with monoclonal anti-idiotope. J. Immunol. 139:1987;2702-2707.
36. Mond J.J., Lees A., Snapper C.M. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:1995;655-692.
37. Moore P.S. Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin. Infect. Dis. 14:1992;515-525.
38. Nakamura M., Tsumoto K., Ishimura K., Kumagai I. Phage library panning against cytosolic fraction of cells using quantitative dot blotting assay: application of selected VH to histochemistry. J. Immunol. Methods. 261:2002;65-72.
39. Oldenburg K.R., Loganathan D., Goldstein I.J., Schultz P.G., Gallop M.A. Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. U. S. A. 89:1992;5393-5397.
40. O'Neil K.T., Hoess R.H., Jackson S.A., Ramachandran N.S., Mousa S.A., DeGrado W.F. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins. 14:1992;509-515.
41. Parmley S.F., Smith G.P. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene. 73:1988;305-318.
42. Peeters C.C., Tenbergen-Meekes A.M., Poolman J.T., Beurret M., Zegers B.J., Rijkers G.T. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect. Immun. 59:1991;3504-3510.
43. Phalipon A., Folgori A., Arondel J., Sgaramella G., Fortugno P., Cortese R., Sansonetti P.J., Felici F. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur. J. Immunol. 27:1997;2620-2625.
44. Pincus S.H., Smith M.J., Jennings H.J., Burritt J.B., Glee P.M. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen. J. Immunol. 160:1998;293-298.
45. Pinilla C., Appel J.R., Campbell G.D., Buencamino J., Benkirane N., Muller S., Greenspan N.S. All-D peptides recognized by an anti-carbohydrate antibody identified from a positional scanning library. J. Mol. Biol. 283:1998;1013-1025.
46. Poolman J.T., Hopman C.T.P., Zanen H.C. Problems in the definition of meningococcal serotypes. FEMS Microbiol. Lett. 13:1982;339-348.
47. Raychaudhuri S., Kang C.Y., Kaveri S.V., Kieber-Emmons T., Kohler H. Tumor idiotype vaccines: VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2. J. Immunol. 145:1990;760-767.
48. Raymond N.J., Reeves M., Ajello G., Baughman W., Gheesling L.L., Carlone G.M., Wenger J.D., Stephens D.S. Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease. J. Infect. Dis. 176:1997;1277-1284.
49. Richmond P., Borrow R., Goldblatt D., Findlow J., Martin S., Morris R., Cartwright K., Miller E. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J. Infect. Dis. 183:2001;160-163.
50. Riedo F.X., Plikaytis B.D., Broome C.V. Epidemiology and prevention of meningococcal disease. Pediatr. Infect. Dis. J. 14:1995;643-657.
51. Rijkers G.T., Sanders E.A., Breukels M.A., Zegers B.J. Infant B cell responses to polysaccharide determinants. Vaccine. 16:1998;1396-1400.
52. Rosenstein N.E., Perkins B.A., Stephens D.S., Lefkowitz L., Cartter M.L., Danila R., Cieslak P., Shutt K.A., Popovic T., Schuchat A., Harrison L.H., Reingold A.L. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis. 180:1999;1894-1901.
53. Ruben F.L., Froeschle J.E., Meschievitz C., Chen K., George J., Reeves-Hoche M.K., Pietrobon P., Bybel M., Livingood W.C., Woodhouse L. Choosing a route of administration for quadrivalent meningococcal polysaccharide vaccine: intramuscular versus subcutaneous. Clin. Infect. Dis. 32:2001;170-172.
54. Salit I.E., Tomalty L. Experimental meningococcal infection in neonatal mice: differences in virulence between strains isolated from human cases and carriers. Can. J. Microbiol. 30:1984;1042-1045.
55. Schreiber J.R., Nixon K.L., Tosi M.F., Pier G.B., Patawaran M.B. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa: II. Isotype and functional activity of the anti-idiotype-induced antibodies. J. Immunol. 146:1991;188-193.
56. Scott J.K., Smith G.P. Searching for peptide ligands with an epitope library. Science. 249:1990;386-390.
57. Scott J.K., Loganathan D., Easley R.B., Gong X., Goldstein I.J. A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc. Natl. Acad. Sci. U. S. A. 89:1992;5398-5402.
58. Smith G.P., Scott J.K. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217:1993;228-257.
59. Timens W., Boes A., Rozeboom-Uiterwijk T., Poppema S. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J. Immunol. 143:1989;3200-3206.
60. Twumasi P.A. Jr., Kumah S., Leach A., O'Dempsey T.J., Ceesay S.J., Todd J., Broome C.V., Carlone G.M., Pais L.B., Holder P.K.et al. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J. Infect. Dis. 171:1995;632-638.
61. Valadon P., Scharff M.D. Enhancement of ELISAs for screening peptides in epitope phage display libraries. J. Immunol. Methods. 197:1996;171-179.
62. Valadon P., Nussbaum G., Boyd L.F., Margulies D.H., Scharff M.D. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J. Mol. Biol. 261:1996;11-22.
63. Valadon P., Nussbaum G., Oh J., Scharff M.D. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide. J. Immunol. 161:1998;1829-1836.
64. van Deuren M., Brandtzaeg P., van der Meer J.W. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13:2000;144-166. (table of contents).
65. Westerink M.A., Giardina P.C. Anti-idiotype induced protection against Neisseria meningitidis serogroup C bacteremia. Microb. Pathog. 12:1992;19-26.
66. Westerink M.A., Campagnari A.A., Wirth M.A., Apicella M.A. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C. Infect. Immun. 56:1988;1120-1127.
67. Westerink M.A., Giardina P.C., Campagnari A.A., Apicella M.A. The thymus-dependent nature of the murine antibody response to a monoclonal anti-idiotypic antibody to the Neisseria meningitidis serogroup C capsular polysaccharide. Microb. Pathog. 8:1990;411-419.
68. Westerink M.A., Giardina P.C., Apicella M.A., Kieber-Emmons T. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. U. S. A. 92:1995;4021-4025.
69. Zollinger W.D., Mandrell R.E., Griffiss J.M., Altieri P., Berman S. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J. Clin. Invest. 63:1979;836-848.